Divalent Copper as a Major Triggering Agent in Alzheimer's Disease (Q28260134)

https://api.crossref.org/works/10.3233%2FJAD-143123

Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Substoichiometric levels of Cu2+ ions accelerate the kinetics of fiber formation and promote cell toxicity of amyloid-{beta} from Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

The risks of free copper in the body and the development of useful anticopper drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Dietary copper and high saturated and trans fat intakes associated with cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Prevalence and etiology of dementia in a Japanese community

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Excess of serum copper not related to ceruloplasmin in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Elevated labile Cu is associated with oxidative pathology in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Speciation of copper in a range of food types by X-ray absorption spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

How copper traverses cellular membranes through the mammalian copper transporter 1, Ctr1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Recognition, diagnosis, and management of Wilson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Meat intake and mortality: a prospective study of over half a million people

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Dietary supplements and mortality rate in older women: the Iowa Women's Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Low-copper diet as a preventive strategy for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Alzheimer's disease as copper deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin II. The denture cream is a primary source of excessive zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143123

21 January 2018

Identifiers

DOI

10.3233/JAD-143123

1 reference

Consolidated OpenCitations Corpus – April 2017

82770

82770

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference